Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG

Vi capsular polysaccharide (Vi) conjugate vaccines, which can prevent typhoid in infants and young children, are being developed. Comparative immunogenicity studies are facilitated by an International Standard (IS) for human anti-Vi IgG. 16/138, a pool of sera from volunteers which received either V...

Descripción completa

Detalles Bibliográficos
Autores principales: Rijpkema, Sjoerd, Hockley, Jason, Logan, Alastair, Rigsby, Peter, Atkinson, Eleanor, Jin, Celina, Goldblatt, David, Liang, Haoyu, Bachtiar, Novilia S., Yang, Jae Seung, Goel, Akshay, Ramasamy, Venkatesan, Pasetti, Marcela F., Pollard, Andrew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academic Press 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238147/
https://www.ncbi.nlm.nih.gov/pubmed/30201529
http://dx.doi.org/10.1016/j.biologicals.2018.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238147/
https://www.ncbi.nlm.nih.gov/pubmed/30201529
http://dx.doi.org/10.1016/j.biologicals.2018.09.001

Ejemplares similares